Almirall (ALM)

9.830 +0.060 (+0.61%)
Close EUR Disclaimer

Almirall Company Profile

Equity Type
Almirall, S.A., a biopharmaceutical company, engages in the purchase, manufacture, storage, and sale of skin-health medicines in Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising actinic keratosis, atopic dermatitis, alopecia areata, skin cancer, psoriasis, onychomycosis, vitiligo, hidradenitis suppurativa, oncodermatology, acne, orphan indications, and rare skin diseases, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musculo-skeletal, respiratory, and nervous system; dermatologicals; genito urinary system and sex hormones; immunostimulants; and systematic hormonal preparations. It has a multi-target alliance with Etherna to research and develop new mRNA-based therapies for severe skin diseases, including non-melanoma skin cancer. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain.
Contact Information
Barcelona,08022 Spain
34 93 291 30 00
Top Executives
Thomas Fulton Wilson McKillop 80 2009 Independent First Vice Chairman
Sidney Taurel 74 2009 Member of Global Advisory Board-Spain
Karin Louise Dorrepaal 62 2013 External Independent Director
Eva-Lotta Coulter 64 2020 Independent Director
Alexandra B. Kimball 55 2020 Independent Director
Ruud Dobber 0 2021 Independent Director
Seth J. Orlow 65 2016 External Independent Director
Antonio Gallardo Torrededia 57 2014 Proprietary Director
Enrique de Leyva Perez 64 2019 Lead Independent Director
Carlos Gallardo Piqué 52 2014 CEO, President, Member of Management Board & Chairman of the Board
Clear All
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles